Navigation Links
Rochester Medical Director Schnobrich to Retire
Date:12/23/2011

STEWARTVILLE, Minn., Dec. 23, 2011 /PRNewswire/ -- Rochester Medical Corporation (Nasdaq: ROCM) announced today that Roger W. Schnobrich will retire from its Board of Directors following the conclusion of the Company's 2012 Annual Meeting of Shareholders to be held on January 26, 2012, which is the end of his current term.

Board Chairman and CEO Anthony J. Conway stated that "Mr. Schnobrich has served on our Board since 1995.  His cheerful intelligence and gracious temperament have served the Company well.  He is a man of excellent character and dignity, and Rochester Medical Corporation has benefited greatly from these traits over the years.

"Our many thanks for working with us, Roger. I know you will continue to enjoy each day."

Conway continued, "I am very pleased to announce that the Board of Directors has nominated Peter H. Shepard for election as a Director for Rochester Medical Corporation at the 2012 Annual Meeting.  Mr. Shepard has deep knowledge and experience in the medical device industry and is particularly expert in the field of Urology and Incontinence.  Mr. Shepard's extensive sales and marketing experience will enable him to provide valuable insight and guidance to our management team with respect to our strategic initiatives to grow sales domestically and internationally."

About Rochester Medical Corporation

Rochester Medical Corporation develops, manufactures, and markets disposable medical catheters and devices for urological and continence care applications.  The Company also sells certain ostomy and wound and scar care products and other brands of urological products into the European marketplace.

For further information, please contact Anthony J. Conway, President and Chief Executive Officer or David A. Jonas, Chief Financial Officer of Rochester Medical Corporation at (507) 533-9600 or Parice Halbert, CFA, at Westwicke Partners (443) 213-0500.  More information about the 2012 Annual Meeting of Shareholders is included in the Company's proxy statement filed with the Securities and Exchange Commission on December 23, 2011.  More information about Rochester Medical is available on its website at http://www.rocm.com.


'/>"/>
SOURCE Rochester Medical Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Rochester Medical Reports Fourth Quarter and Fiscal Year End Results
2. Rochester Medical Announces Fourth Quarter 2011 Earnings Conference Call Thursday, November 3, 2011
3. Rochester Medical Implants Relocates to New Facility in Noblesville, IN
4. Rochester Medical Reports Fiscal 2011 Third Quarter Results
5. Rochester Medical Announces Third Quarter 2011 Earnings Conference Call Thursday, July 28, 2011
6. Rochester Medical Reports Second Quarter Results
7. Rochester Medical Announces Second Quarter 2011 Earnings Conference Call Thursday, May 5, 2011
8. Rochester Medical Completes Acquisition of Laprolan
9. Fornix Shareholders Approve the Sale of Laprolan B.V. to Rochester Medical Corporation
10. Rochester Medical Reports First Quarter Results and Recent Developments
11. Rochester Medical Announces First Quarter 2011 Earnings Conference Call Tuesday, January 25, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016  Guerbet announced today that ... Supplier Horizon Award . One of ... was recognized for its support of Premier members through ... clinical excellence, and commitment to lower costs. ... this recognition of our outstanding customer service from Premier," ...
(Date:6/23/2016)... Research and Markets has announced ... Analysis (United States, China, Japan, Brazil, United Kingdom, Germany, ... offering. Surgical Procedure ... planners, provides surgical procedure volume data in a geographic ... in-depth analysis of growth drivers and inhibitors, including world ...
(Date:6/23/2016)... 23, 2016 The Biotechnology industry ... to present great opportunities to investors. Stock-Callers.com assesses the ... Corp. (NYSE: XON ), Vertex Pharmaceuticals Inc. ... ARNA ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... and receive your complimentary trade alerts at: ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
Breaking Medicine News(10 mins):